Select Medical Q3 Earnings and Revenues Surpass Estimates
| QURE Stock | USD 6.02 0.03 0.50% |
About 61% of Uniqure NV's investor base is looking to short. The analysis of the overall investor sentiment regarding Uniqure NV suggests that many traders are alarmed. The current market sentiment, together with Uniqure NV's historical and current headlines, can help investors time the market. In addition, many technical investors use Uniqure NV stock news signals to limit their universe of possible portfolio assets.
Uniqure |
Select Medical delivered earnings and revenue surprises of 38.89 percent and 2.30, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock
Read at zacks.com
 |
Uniqure NV Fundamental Analysis
We analyze Uniqure NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Uniqure NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Uniqure NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Uniqure NV is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Uniqure NV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Uniqure NV stock to make a market-neutral strategy. Peer analysis of Uniqure NV could also be used in its relative valuation, which is a method of valuing Uniqure NV by comparing valuation metrics with similar companies.
Peers
Uniqure NV Related Equities
| XFOR | X4 Pharmaceuticals | 11.43 | ||||
| MGTX | MeiraGTx Holdings | 3.36 | ||||
| DAWN | Day One | 1.53 | ||||
| SNDX | Syndax Pharmaceuticals | 1.27 | ||||
| RCKT | Rocket Pharmaceuticals | 0.64 | ||||
| ABOS | Acumen Pharmaceuticals | 0.44 | ||||
| PCVX | Vaxcyte | 0.38 | ||||
| REPL | Replimune | 0.21 | ||||
| SLDB | Solid Biosciences | 0.18 | ||||
| MRUS | Merus BV | 0.29 | ||||
| RYTM | Rhythm Pharmaceuticals | 0.34 | ||||
| INZY | Inozyme Pharma | 0.37 | ||||
| RNA | Avidity Biosciences | 0.69 | ||||
| RGNX | Regenxbio | 0.90 | ||||
| KNSA | Kiniksa Pharmaceuticals | 1.08 | ||||
| PHAT | Phathom Pharmaceuticals | 1.32 | ||||
| STRO | Sutro Biopharma | 1.49 | ||||
| TERN | Terns Pharmaceuticals | 1.58 | ||||
| GPCR | Structure Therapeutics | 1.78 | ||||
| PTGX | Protagonist Therapeutics | 2.56 | ||||
| AMLX | Amylyx Pharmaceuticals | 3.48 | ||||
| LRMR | Larimar Therapeutics | 4.67 |
Complementary Tools for Uniqure Stock analysis
When running Uniqure NV's price analysis, check to measure Uniqure NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Uniqure NV is operating at the current time. Most of Uniqure NV's value examination focuses on studying past and present price action to predict the probability of Uniqure NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Uniqure NV's price. Additionally, you may evaluate how the addition of Uniqure NV to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |